New Laser — Only 4-lbs — Offers Targeted Treatment, Novel Design

Fremont, CA - April 21, 2008  - HOYA ConBio^TM, a global leader in dental and aesthetic lasers, today announced the US launch of the V-Raser diode laser for treatment of vascular lesions.  The extremely compact V-Raser was unveiled at the 28^th Annual Conference of the American Society for Laser Medicine & Surgery, offering physicians an effective solution for common red and blue blood vessels, including facial telangiectasias.

“The V-Raser is uniquely suited to be an integral part of any aesthetic medical practice,” said Timothy S. Gehlmann, President & CEO, HOYA ConBio.  “The targeted design of the V-Raser complements other laser and light based therapies for comprehensive treatment of photodamaged and photoaged skin.  Because facial spider veins are so common, physicians will be able to use this laser on virtually every one of their cosmetic patients.”

The 980 nm wavelength of the diode laser offers safe, effective treatment of high-flow blood vessels, including red and blue vessels especially on the face.  Variable spot sizes allow physicians to reach small, hard-to-treat areas such as the crevices and sides of the nose. Resolution is achieved in one to three treatments, depending on the size of the vessel.

“The V-Raser is a revolutionary new vascular lesion laser that’s different from anything else out there,” said David Goldberg, MD, Director, Skin Laser & Surgery Specialists of NY/NJ and Clinical Professor of Dermatology at Mount Sinai School of Medicine. “The ideal patient is that individual who has photodamage and a variety of blood vessels, including telangiectasias, on his/her cheeks and nose.  The V-Raser is uniquely successful in removing a variety of facial vessels with minimal patient discomfort.  And, it’s the smallest laser I’ve ever seen.”

Weighing only four pounds, the V-Raser is extremely compact and can fit anywhere in a physician’s clinic.  Priced at $29,950, the V-Raser is a cost-effective tool introduced by Hoya ConBio, developers of the MedLite and RevLite Q-Switched Nd: YAG lasers, widely regarded as workhorses of the aesthetic industry.

About Hoya ConBio: HOYA ConBio designs, manufactures and markets sophisticated laser systems used in dental and aesthetic medical practices worldwide, widely recognized by practitioners as “The World’s Most Reliable Lasers^TM.”  The company’s innovative technologies are highly versatile, clinically effective, and offer rapid return on investment.  Headquartered in Fremont, CA, HOYA ConBio maintains a worldwide product and service distribution network. For more information, call 800-532-1064 or visit www.conbio.com.

Eclipse Medical to Offer HOYA ConBio Lasers in Four-State Southern Region

Fremont, CA – July 30 – HOYA ConBio™, a global leader in dental and aesthetic medical laser technology, today announced an exclusive agreement for the MedLite C Series and RevLite lasers with Eclipse Medical Ltd., a leading distributor of aesthetic high-tech medical devices and supplies. The three-year agreement will give Eclipse Medical exclusive rights to distribute HOYA ConBio™ aesthetic lasers to medical professionals in Texas, Louisiana, Arkansas and Oklahoma.

RevLite and MedLite C Series lasers are advanced, highly versatile aesthetic systems that represent the next generation of Q-switched engineering. Safe for use on all skin types, the EO Q-switched Nd:YAG lasers deliver energy with a PhotoAcoustic effect — an efficient, patient-friendly alternative to devices that rely on photothermal (heat) action. Known worldwide as the gold standard for tattoo removal, HOYA ConBio lasers offer solutions for wrinkle reduction, acne scars, vascular and pigmented lesions, and hair removal. The RevLite, launched in 2007, features PhotoAcoustic Technology Pulse™ (PTP), a unique pulse dispersion that enables physicians to harness up to 60 percent more power.

Fremont, CA, January 2007 - HOYA ConBio^TM, a leading provider of laser solutions for medical and dental professionals worldwide, announces the introduction of AimLite^TM, a new aiming beam that optimizes its MedLite^TM Q-switched Nd: YAG laser system’s newest applications, including facial skin-toning and treatment of acne scarring.

“Since these newer facial treatments occur closer to the eye and lips, AimLite^TM provides for optimal placement of the laser energy in these areas,” said Timothy Gehlmann, President & CEO of HOYA ConBio. “AimLite^TM also guides the user when the laser is in the single pulse mode, particularly for work on acne scars and spider veins, where accuracy is essential,” he said.

“As we continue to expand the applications for this versatile and robust laser, we will offer additional accessories that optimize its performance. We are committed to providing physicians and other medical providers with laser systems versatile enough for all aesthetic applications and skin types,” Mr. Gehlmann added. “We continue to focus on new applications. As a result, MedLite^TM has become the system of choice in hundreds of physician practices, hospitals and spas around the world.”

AimLite^TM is now included as a standard accessory with all lasers. AimLite^TM is also available as an option easily added to MedLite^TM lasers already in use throughout the world. The accessory option comes complete with installation details.

About HOYA ConBio^TM

A U.S.-based laser manufacturer, HOYA ConBio^TM designs, manufactures and markets sophisticated laser systems used in aesthetic, medical and dental practices worldwide. The company’s innovative technologies are highly versatile, effective, and offer rapid return on investment.

The company’s MedLite^TM Q-switched Nd: YAG laser series is used in high-demand aesthetic laser procedures including facial skin toning and rejuvenation, and the treatment of wrinkles, spider veins, scars and acne, and the reduction of hair, tattoos and age spots. The company markets its MedLite^TM laser series to dermatologists, plastic surgeons, family and ob-gyn practices, and medical spas worldwide.

HOYA ConBio^TM designs, manufactures and markets two separate laser systems to the global dental community: the VersaWave^TM Er: YAG All-Tissue Laser and the DioDent^TM Soft Tissue Diode Laser series. The company’s VersaWave^TM is used in dental applications for aesthetic tissue recontouring, frenectomies, direct preparations and closed flap bone recontouring. The VersaWave^TM features high repetition rates, high power output, and exceptional delivery ergonomics. The DioDent^TM II series provides a cost-effective way for dentists to bring the newest generation of diode laser technology to their practices and is ideal for hygiene maintenance programs, soft tissue and aesthetic dental procedures. Both the VersaWave^TM and the DioDent^TM II offer operational versatility and portability.

Headquartered in Fremont, CA, HOYA ConBio^TM has offices in Europe and Japan and maintains a worldwide product and service distribution network. HOYA ConBio^TM is based at 47733 Fremont Boulevard, Fremont, CA 94538. Tel., 800-532-1064 and 510-445-4500; Fax, 510-445-4550; Email: info@conbio.com. HOYA ConBio^TM is a subsidiary of HOYA Corporation, a leader in optical solutions for information technology, vision care and photonics.

About HOYA Corporation

Since its establishment in 1941 as Japan’s first specialty manufacturer of optical glass, Hoya has diversified into new business areas that exploit the potential of advanced optics technologies. The company has continued to grow as a global enterprise through the expansion of its diverse business activities, which encompass electro-optics, photonics, vision care, healthcare and crystal products. Hoya will continue to maximize its corporate value for the benefit of all stakeholders in the company in accordance with the following corporate mission: “We will pursue creativity and innovation in the fields of Information Technology, Healthcare, and Lifestyle Refinement, and contribute to creating a truly prosperous society, while promoting harmony among humankind, society, and nature”.

Fremont, CA, January 2007 – HOYA ConBio™, a leading provider of laser solutions for medical and dental practices worldwide, announced today that its new chromophore-clearing device, the PurpuraLite™, can be used to minimize or eliminate purpura that typically results from certain aesthetic laser treatments.

Purpura is the purplish discoloration in the skin, resulting from minor bleeding within the skin that often appears following laser treatment. PurpuraLite™ allows the physician to temporarily “empty” the fine blood vessels under the treatment area, eliminating the “red” chromophore that would typically absorb energy and create a purpuric response. By moving the red blood cells out of the way, red blood cells are not disrupted and purpura is avoided.

“ PurpuraLite™ exemplifies our ongoing commitment to establishing our MedLite™ laser as the first and only system versatile enough for all aesthetic applications and skin types,” said Timothy Gehlmann, President & CEO of HOYA ConBio.

“The MedLite™ line of lasers has over 15 years of consistent reliability, safety and unparallel return on investment,” notes the Aesthetic Buyers Guide, March/April 2006. (www.miinews.com)“With the fastest treatment periods available, MedLite™ lasers’ dollar per minute (DPM) return is unmatched.”

PurpuraLite™ is now shipped as a standard accessory with all MedLite™ lasers, and can be purchased as an option to lasers already in use throughout the world.

About HOYA ConBio™

A U.S.-based laser manufacturer, HOYA ConBio™ designs, manufactures and markets sophisticated laser systems used in aesthetic, medical and dental practices worldwide. The company’s innovative technologies are highly versatile, effective, and offer rapid return on investment.

The company’s MedLite™ Q-switched Nd: YAG laser series is used in high-demand aesthetic laser procedures including facial skin toning and rejuvenation, and the treatment of wrinkles, spider veins, scars and acne, and the reduction of hair, tattoos and age spots. The company markets its MedLite™ laser series to dermatologists, plastic surgeons, family and ob-gyn practices, and medical spas worldwide.

HOYA ConBio™ designs, manufactures and markets two separate laser systems to the global dental community: the VersaWave™ Er: YAG All-Tissue Laser and the DioDent™ Soft Tissue Diode Laser series. The company’s VersaWave™ is used in dental applications for aesthetic tissue recontouring, frenectomies, direct preparations and closed flap bone recontouring. The VersaWave™ features high repetition rates, high power output, and exceptional delivery ergonomics. The DioDent™ II series provides a cost-effective way for dentists to bring the newest generation of diode laser technology to their practices and is ideal for hygiene maintenance programs, soft tissue and aesthetic dental procedures. Both the VersaWave™ and the DioDent™ II offer operational versatility and portability.

Headquartered in Fremont, CA, HOYA ConBio™ has offices in Europe and Japan and maintains a worldwide product and service distribution network. HOYA ConBio™ is based at 47733 Fremont Boulevard, Fremont, CA 94538. Tel., 800-532-1064 and 510-445-4500; Fax, 510-445-4550; Email: info@conbio.com. HOYA ConBio™ is a subsidiary of HOYA Corporation, a leader in optical solutions for information technology, vision care and photonics.

About HOYA Corporation

HOYA ConBio is proud to announce that the MedLite® C6 has been FDA approved for laser skin resurfacing for the treatment of acne scars and wrinkles. This adds yet another indication for this laser, which already includes epidermal and dermal pigmented lesion removal, advanced tattoo removal, laser-assisted hair removal and vascular lesion treatment.

With the popularity of this procedure rising, the MedLite® C6 is fast becoming the laser of choice for this treatment. When using the MediLite®, there is little risk of pigmentary changes or burns, and no risk of pitted scars. Patients report and doctors have confirmed that they have achieved a more refreshed appearance, a reduction in fine lines and wrinkles, smoother skin texture, and a decrease in pore size. The MedLite® was discovered to be effective in this application when treating patients for other indications. Physicians discovered that their patients were noticing these non-ablative resurfacing benefits. Paul Jarrod Frank, MD, Director of 5th Avenue Dermatology Surgery & Laser Center, and a pioneer in minimally invasive cosmetic surgery, has been using this technology with great success for 3 years. “The Medlite Laser toning procedure offers patients the safest and least invasive way to effectively minimize the appearance of wrinkles and scars in any skin type. Used alone or in combination with other procedures, laser toning is a standard in minimally invasive cosmetic rejuvenation”, says Dr Frank.

A study conducted by Paul Friedman, MD and Roy Geronemus, MD (Laser & Skin Surgery Center of New York) used 3-D in-vivo optical skin imaging to objectively quantify the efficacy of multiple treatment sessions with the MedLite® for acne scarring. The researchers also looked to determine improved efficacy after multiple treatment sessions, and biomechanically characterize nonablative skin rejuvenation. It was found that in less than five treatment sessions, patients experienced quantifiable improvement of surface topography, and in skin tone.

For more information on the MedLite® C Series, please contact the company headquarters at 800-532-1064 or visit the company’s website at www.conbio.com.